{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:28:08Z","timestamp":1791120488110,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T00:00:00Z","timestamp":1304812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1479-5876-9-55","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T06:17:48Z","timestamp":1305008268000},"source":"Crossref","is-referenced-by-count":56,"title":["Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I\/II clinical trial, following preclinical studies to ensure safety"],"prefix":"10.1186","volume":"9","author":[{"given":"Akio","family":"Ido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Marusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Setoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Deok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yokode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,8]]},"reference":[{"key":"722_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0140-6736(93)91818-7","volume":"342","author":"JG O'Gray","year":"1993","unstructured":"O'Gray JG, Schalm SW, Williams R: Acute liver failure: redefining the syndromes. Lancet. 1993, 342: 273-10.1016\/0140-6736(93)91818-7.","journal-title":"Lancet"},{"key":"722_CR2","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/hep.22177","volume":"47","author":"WM Lee","year":"2008","unstructured":"Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH: Acute liver failure: summary of a workshop. Hepatology. 2008, 47: 1401-1415. 10.1002\/hep.22177.","journal-title":"Hepatology"},{"key":"722_CR3","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1002\/lt.21612","volume":"14","author":"P Ichai","year":"2008","unstructured":"Ichai P, Samuel D: Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008, 14: S67-S79. 10.1002\/lt.21612.","journal-title":"Liver Transpl"},{"key":"722_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1872-034X.2008.00322.x","volume":"38","author":"K Fujiwara","year":"2008","unstructured":"Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G: Intractable Liver Diseases Study Group of Japan, fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res. 2008, 38: 646-657. 10.1111\/j.1872-034X.2008.00322.x.","journal-title":"Hepatol Res"},{"key":"722_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/gut.20.7.620","volume":"20","author":"N Tygstrup","year":"1979","unstructured":"Tygstrup N, Juhl E: Randomized trial of steroid therapy in acute liver failure. Report from the European Association for the Study of the Liver (EASL). Gut. 1979, 20: 620-623. 10.1136\/gut.20.7.620.","journal-title":"Gut"},{"key":"722_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.21486","volume":"45","author":"M Kumar","year":"2007","unstructured":"Kumar M, Satapathy S, Monga R, Das K, Hissar S, Pande C, Sharma BC, Sarin SK: A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology. 2007, 45: 97-101. 10.1002\/hep.21486.","journal-title":"Hepatology"},{"key":"722_CR7","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1572-0241.2001.03706.x","volume":"96","author":"JO Clemmesen","year":"2001","unstructured":"Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P: Effect of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol. 2001, 96: 1217-1223. 10.1111\/j.1572-0241.2001.03706.x.","journal-title":"Am J Gastroenterol"},{"key":"722_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0014-4827(86)90514-8","volume":"166","author":"E Gohda","year":"1986","unstructured":"Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Hashimoto S, Daikuhara Y: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Ex Cell Res. 1986, 166: 139-150. 10.1016\/0014-4827(86)90514-8.","journal-title":"Ex Cell Res"},{"key":"722_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1172\/JCI113334","volume":"81","author":"E Gohda","year":"1988","unstructured":"Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikukhara Y: Purification and partial characterization of hepatocyte growth factor from plasma of patients with fulminant hepatic failure. J Clin Invest. 1988, 81: 414-419. 10.1172\/JCI113334.","journal-title":"J Clin Invest"},{"key":"722_CR10","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/0270-9139(93)90237-H","volume":"18","author":"K Fujiwara","year":"1993","unstructured":"Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, Higashio K, Kurokawa K: Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology. 1993, 18: 1443-1449. 10.1016\/0270-9139(93)90237-H.","journal-title":"Hepatology"},{"key":"722_CR11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/oxfordjournals.jbchem.a124814","volume":"117","author":"T Ishii","year":"1995","unstructured":"Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T, Niwa T, Umezu K, Yuasa S: Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem. 1995, 117: 1105-1112.","journal-title":"J Biochem"},{"key":"722_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1006\/bbrc.2000.4063","volume":"280","author":"A Moriuchi","year":"2001","unstructured":"Moriuchi A, Hirono S, Ido A, Ochiai T, Nakama T, Uto H, Hori T, Hayashi K, Tsubouchi H: Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Biochem Biophys Res Commun. 2001, 280: 368-373. 10.1006\/bbrc.2000.4063.","journal-title":"Biochem Biophys Res Commun"},{"key":"722_CR13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1111\/j.1440-1746.2005.03922.x","volume":"20","author":"S Hasuike","year":"2005","unstructured":"Hasuike S, Ido A, Uto H, Moriuchi A, Tahara Y, Nagata K, Hori T, Hayashi K, Tsubouchi H: Hepatocyte growth factor accelerates the proliferation and differentiation of hepatic oval cells in a 2-acetylaminofluorene\/partial hepatectomy model in rats. J Gastroenterol Hepatol. 2005, 20: 1753-1761. 10.1111\/j.1440-1746.2005.03922.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"722_CR14","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.0306068101","volume":"101","author":"CG Huh","year":"2004","unstructured":"Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS: Hepatocyte growth factor\/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA. 2004, 101: 4477-4482. 10.1073\/pnas.0306068101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"722_CR15","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1073\/pnas.0403412101","volume":"101","author":"M Borowiak","year":"2004","unstructured":"Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C: Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA. 2004, 101: 10608-10613. 10.1073\/pnas.0403412101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"722_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/sj.cdd.4401172","volume":"10","author":"M Ozaki","year":"2003","unstructured":"Ozaki M, Haga S, Zhang HQ, Irani K, Suzuki S: Inhibition of hypoxia\/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 2003, 10: 508-515. 10.1038\/sj.cdd.4401172.","journal-title":"Cell Death Differ"},{"key":"722_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/hep.20138","volume":"39","author":"H Schulze-Bergkamen","year":"2004","unstructured":"Schulze-Bergkamen H, Brenner D, Krueger A, Suess D, Fas SC, Frey CR, Dax A, Zink d, Buchler P, Muller M, Krammer PH: Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology. 2004, 39: 645-654. 10.1002\/hep.20138.","journal-title":"Hepatology"},{"key":"722_CR18","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/hep.21604","volume":"45","author":"A Moumen","year":"2007","unstructured":"Moumen A, Ieraci A, Patane S, Sole C, Comella JX, Dono R, Maina F: Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3K-Akt-dependent manner. Hepatology. 2007, 45: 1210-1217. 10.1002\/hep.21604.","journal-title":"Hepatology"},{"key":"722_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/hep.510260136","volume":"26","author":"J Okano","year":"1997","unstructured":"Okano J, Shiota G, Kawasaki H: Protective action of hepatocyte growth factor for liver injury caused by D-galactosamine in transgenic mice. Hepatology. 1997, 26: 241-1249. 10.1002\/hep.510260136.","journal-title":"Hepatology"},{"key":"722_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1006\/bbrc.1998.8293","volume":"244","author":"K Kosai","year":"1998","unstructured":"Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T: Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun. 1998, 244: 683-690. 10.1006\/bbrc.1998.8293.","journal-title":"Biochem Biophys Res Commun"},{"key":"722_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/hep.510300102","volume":"30","author":"K Kosai","year":"1999","unstructured":"Kosai K, Matsumoto K, Funakoshi H, Nakamura T: Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology. 1999, 30: 51-159. 10.1002\/hep.510300102.","journal-title":"Hepatology"},{"key":"722_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hep.1840130102","volume":"13","author":"H Tsubouchi","year":"1991","unstructured":"Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawasaki S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology. 1991, 13: 1-5. 10.1002\/hep.1840130102.","journal-title":"Hepatology"},{"key":"722_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.hepres.2004.09.002","volume":"30","author":"A Ido","year":"2004","unstructured":"Ido A, Moriuchi A, Kim IL, Numata M, Nagata-Tsubouchi Y, Hasuike S, Uto H, Tsubouchi H: Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res. 2004, 30: 175-181. 10.1016\/j.hepres.2004.09.002.","journal-title":"Hepatol Res"},{"key":"722_CR24","first-page":"503","volume":"17","author":"K Kusumoto","year":"2006","unstructured":"Kusumoto K, Ido A, Moriuchi A, Katsura T, Kim IL, Takahama Y, Numata M, Kodama M, Hasuike S, Nagata K, Uto H, Inui K, Tsubouchi H: Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Int J Mol Med. 2006, 17: 503-509.","journal-title":"Int J Mol Med"},{"key":"722_CR25","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1172\/JCI115207","volume":"87","author":"AJ Strain","year":"1991","unstructured":"Strain AJ, Ismail T, Tsubouchi H, Arakaki N, Hishida T, Kitamura N, Daikuhara Y, McMaster P: Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest. 1991, 87: 1853-1857. 10.1172\/JCI115207.","journal-title":"J Clin Invest"},{"key":"722_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1124\/jpet.103.054106","volume":"307","author":"Y Tahara","year":"2003","unstructured":"Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T, Hayashi K, Tsubouchi H: Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther. 2003, 307: 146-151. 10.1124\/jpet.103.054106.","journal-title":"J Pharmacol Exp Ther"},{"key":"722_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/hep.1840090615","volume":"9","author":"H Tsubouchi","year":"1989","unstructured":"Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Miyazaki H, Sugihara J, Tomita E, Muro Y, Daikuhara Y, Hashimoto S: Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology. 1989, 9: 875-881. 10.1002\/hep.1840090615.","journal-title":"Hepatology"},{"key":"722_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0140-6736(92)92396-W","volume":"340","author":"H Tsubouchi","year":"1992","unstructured":"Tsubouchi H, Kawakami S, Hirono S, Miyazaki H, Kimoto M, Arima T, Sekiyama K, Yoshiba N, Arakaki Y, Daikuhara Y: Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor. Lancet. 1992, 340: 307-10.1016\/0140-6736(92)92396-W.","journal-title":"Lancet"},{"key":"722_CR29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1034\/j.1399-0012.1999.130616.x","volume":"13","author":"S Eguchi","year":"1999","unstructured":"Eguchi S, Okudaira S, Azuma T, Ohno Y, Fujioka H, Furui J, Tanaka K, Kanematsu T: Changes in liver regenerative factors in a case of living-related liver transplantation. Clin Tlanspl. 1999, 13: 536-544. 10.1034\/j.1399-0012.1999.130616.x.","journal-title":"Clin Tlanspl"},{"key":"722_CR30","first-page":"3105","volume":"55","author":"A Ido","year":"1995","unstructured":"Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S: Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res. 1995, 55: 3105-3109.","journal-title":"Cancer Res"},{"key":"722_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1179\/016164101101198659","volume":"23","author":"N Tsuzuki","year":"2001","unstructured":"Tsuzuki N, Miyazawa T, Matsumoto K, Nakamura T, Shima K: Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats. Neurol Res. 2001, 23: 417-424. 10.1179\/016164101101198659.","journal-title":"Neurol Res"},{"key":"722_CR32","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1523\/JNEUROSCI.22-15-06537.2002","volume":"22","author":"W Sun","year":"2002","unstructured":"Sun W, Funakoshi H, Nakamura T: Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci. 2002, 22: 6537-6548.","journal-title":"J Neurosci"},{"key":"722_CR33","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1164\/ajrccm.156.6.9611057","volume":"156","author":"M Yaekashiwa","year":"1997","unstructured":"Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T, Nukiwa T: Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphogenic study. Am J Respir Crit Care Med. 1997, 156: 1937-1944.","journal-title":"Am J Respir Crit Care Med"},{"key":"722_CR34","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/S0003-4975(99)00279-9","volume":"67","author":"H Ueda","year":"1999","unstructured":"Ueda H, Sawa Y, Matsumoto K, Kitagawa-Sakakida S, Kawahira Y, Nakamura T, Kaneda Y, Matsuda H: Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann Thorac Surg. 1999, 67: 1726-1731. 10.1016\/S0003-4975(99)00279-9.","journal-title":"Ann Thorac Surg"},{"key":"722_CR35","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1161\/01.CIR.0000016722.37138.F2","volume":"105","author":"S Miyagawa","year":"2002","unstructured":"Miyagawa S, Sawa Y, Taketani S, Kawaguchi N, Nakamura T, Matsuura N, Matsuda H: Myocardial regeneration therapy for heart failure: hepatycte growth factor enhances the effect of cellular cardiomyoplasty. Circulation. 2002, 105: 2556-2561. 10.1161\/01.CIR.0000016722.37138.F2.","journal-title":"Circulation"},{"key":"722_CR36","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.HYP.33.6.1379","volume":"33","author":"R Morishita","year":"1999","unstructured":"Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, Nakamura T, Higaki J, Ogihara T: Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension. 1999, 33: 1379-1384.","journal-title":"Hypertension"},{"key":"722_CR37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.MIB.0000164192.71381.5c","volume":"11","author":"M Numata","year":"2005","unstructured":"Numata M, Ido A, Moriuchi A, Kim IL, Tahara Y, Yamamoto S, Hasuike S, Nagata K, Miyata Y, Uto H, Tsubouchi H: Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Inflamm Bowel Dis. 2005, 11: 551-518. 10.1097\/01.MIB.0000164192.71381.5c.","journal-title":"Inflamm Bowel Dis"},{"key":"722_CR38","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1073\/pnas.91.10.4357","volume":"91","author":"K Kawaida","year":"1994","unstructured":"Kawaida K, Matsumoto K, Shimazu H, Nakamura T: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994, 91: 4357-4361. 10.1073\/pnas.91.10.4357.","journal-title":"Proc Natl Acad Sci USA"},{"key":"722_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/01.HYP.0000136394.08900.ed","volume":"44","author":"R Morishita","year":"2004","unstructured":"Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, Sawa Y, Matsuda H, Kaneda Y, Ogihara T: Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension. 2004, 44: 203-209. 10.1161\/01.HYP.0000136394.08900.ed.","journal-title":"Hypertension"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-9-55\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T18:20:02Z","timestamp":1548181202000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-9-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-9-55","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,8]]},"article-number":"55"}}